Literature DB >> 20185148

Evaluation of hepatic damage and local immune response in goats immunized with native glutathione S-transferase of Fasciola hepatica.

R Zafra1, R A Pérez-Ecija, L Buffoni, R E Mendes, A Martínez-Moreno, F J Martínez-Moreno, M E Martínez Galisteo, J Pérez.   

Abstract

Worm burden, hepatic damage and local cellular and humoral immune responses were assessed in goats immunized with glutathione-S-transferase and challenged with Fasciola hepatica. Infected but unimmunized and uninfected control groups were also studied. Hepatic damage was evaluated grossly and microscopically. Local immune response was evaluated by (1) microscopical examination of hepatic lymph nodes (HLNs); (2) analysis of the distribution of CD2(+), CD4(+), CD8(+), T-cell receptor gammadelta(+) lymphocytes and immunoglobulin (Ig) G(+) plasma cells; and (3) investigation of the distribution of cells expressing interleukin (IL)-4 and interferon (IFN)-gamma in the hepatic inflammatory infiltrates and HLNs. Immunized animals did not have significant reduction in fluke number, but there was significant (P<0.05) reduction of fluke size relative to the control groups. The lesions in the two infected groups were similar and consisted of fibrous perihepatitis and white tortuous tracts, mainly involving the left hepatic lobe. Microscopical lesions were similar in both infected groups and were typical of chronic fascioliosis. These included portal fibrosis, inflammatory infiltration with plasma cells, formation of lymphoid follicles, accumulation of haemosiderin-laden macrophages and granulomatous foci. Both infected groups had a marked local immune response characterized by infiltration of CD2(+), CD4(+) and CD8(+) T lymphocytes, and IgG(+) plasma cells in hepatic lesions and in HLNs. There was no expression of IL-4 or INF-gamma by cells in the hepatic inflammatory infiltrate, but expression of INF-gamma in HLNs was much lower than that of IL-4, suggesting an immune response dominated by T helper 2 cells. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20185148     DOI: 10.1016/j.jcpa.2010.01.011

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  6 in total

1.  Cathepsin L1 mimotopes with adjuvant Quil A induces a Th1/Th2 immune response and confers significant protection against Fasciola hepatica infection in goats.

Authors:  Abel Villa-Mancera; Alejandro Reynoso-Palomar; Fernando Utrera-Quintana; Lorenzo Carreón-Luna
Journal:  Parasitol Res       Date:  2013-11-12       Impact factor: 2.289

2.  Effect of lipopolysaccharide (LPS) from Ochrobactrum intermedium on sheep experimentally infected with Fasciola hepatica.

Authors:  J M Martínez-Pérez; D Robles-Pérez; F Valcárcel-Sancho; A M González-Guirado; I Casanova-García de Castro; J M Nieto-Martínez; F A Rojo-Vázquez; M Martínez-Valladares
Journal:  Parasitol Res       Date:  2013-06-06       Impact factor: 2.289

3.  Antigen-specific response of CD4+ T cells and hepatic lymph node cells to Fasciola hepatica-derived molecules at the early and late stage of the infection in sheep.

Authors:  Raúl Pérez-Caballero; F Javier Martínez-Moreno; Yolanda Corripio-Miyar; Tom N McNeilly; Krystyna Cwiklinski; John P Dalton; Rafael Zafra; José Pérez; Álvaro Martínez-Moreno; Leandro Buffoni
Journal:  Vet Res       Date:  2021-07-02       Impact factor: 3.683

4.  Association of Fasciola hepatica Infection with Liver Fibrosis, Cirrhosis, and Cancer: A Systematic Review.

Authors:  Claudia Machicado; Jorge D Machicado; Vicente Maco; Angelica Terashima; Luis A Marcos
Journal:  PLoS Negl Trop Dis       Date:  2016-09-28

5.  Financial loss estimation of bovine fasciolosis in slaughtered cattle in South Africa.

Authors:  Ishmael Festus Jaja; Borden Mushonga; Ezekiel Green; Voster Muchenje
Journal:  Parasite Epidemiol Control       Date:  2017-10-12

Review 6.  Fasciola and fasciolosis in ruminants in Europe: Identifying research needs.

Authors:  N J Beesley; C Caminade; J Charlier; R J Flynn; J E Hodgkinson; A Martinez-Moreno; M Martinez-Valladares; J Perez; L Rinaldi; D J L Williams
Journal:  Transbound Emerg Dis       Date:  2017-10-06       Impact factor: 5.005

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.